Oxcarbazepine Tablet, Film Coated
Product Images NDC 70518-4663

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 70518-4663). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a description of a medication in tablet form called OXCaI'baZEPIHE, with a strength of 300 mg. It is manufactured by Breckenridge located in Boca Raton, FL. The recommended usual dosage information can be found in the insert included with the product. The medication should be kept out of the reach of children and stored between 20-25°C (68-77°F). Each package contains 30 tablets. The medication can be stored at 15-30°C (59-86°F) with excursions permitted. The lot number and expiration date are not available in the provided text. The tablets are oval and brown in color. The medication has been repackaged by Remedy, Inc. in Indiana, PA.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This text provides information on an exit rate analysis comparing a treatment group receiving Oxcarbazepine with a placebo group. The log-rank test results indicate a statistically significant p-value of 0.0001. The data includes time on trial from Day 2, with treatment details specified for each group.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

This text provides information on seizure rate analysis between the treatment groups of Oxcarbazepine and Placebo. The log-rank test resulted in a p-value of 0.046, indicating a statistical significance in the difference between the groups in terms of time to the first seizure after the first dose. The data also includes days from the first dose to the first seizure across different time points.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This is a dataset showing exit rates at different time intervals for a high and low treatment group. The exit rates are measured in days, ranging from 10 to 130. This data can be used to analyze the effectiveness of the treatment groups in terms of time to exit.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This is a data table showing the exit rate at different time intervals in days for a high and low treatment group. The data is presented in a numerical format and could be used to analyze the time it takes for individuals to exit the group under different treatments.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.